Unravelling ChemoResistance mechanisms and improving first-line therapeutic strategies in high-grade serous Ovarian Carcinoma using multi-culture patient-derived organoids

Project Information

CROC

Grant agreement ID: 101063359

DOI 10.3030/101063359

EC signature date 13 June 2022

Start date 1 January 2023

End date 31 August 2025

Funded under

• Marie Skłodowska-Curie Actions (MSCA)

Total cost No data

EU contribution € 214 934,40

Coordinated by

KOBENHAVNS UNIVERSITET
Denmark